Orexin receptor 2 agonist reduces symptoms of narcolepsy type 1
1. In this randomized controlled trial, an oral orexin receptor 2 (OX2R) agonist (TAK-994) was associated with improvements in wakefulness, ...
1. In this randomized controlled trial, an oral orexin receptor 2 (OX2R) agonist (TAK-994) was associated with improvements in wakefulness, ...
Click here to read this study in NEJM ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be ...
1. In Alzheimer disease (AD), increased cerebrospinal fluid (CSF) orexin levels were associated with diminished sleep quality, and increased cognitive ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.